Abnormalities of the estrogen receptor in breast cancer — Introduction Suzanne A. W. Fuqua OriginalPaper Pages: 117 - 118
Action of “pure” antiestrogens in inhibiting estrogen receptor action M. G. Parker OriginalPaper Pages: 131 - 137
A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens Shun-Yuan JiangChristopher J. ParkerV. Craig Jordan OriginalPaper Pages: 139 - 147
Investigation of the origin of variant, truncated estrogen receptor-like mRNAs identified in some human breast cancer biopsy samples L. C. MurphyH. DotzlawJ. Schwarz OriginalPaper Pages: 149 - 161
Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells Richard J. MiksicekYing LeiYaolin Wang OriginalPaper Pages: 163 - 174
An estrogen receptor genetic polymorphism and a history of spontaneous abortion — Correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer Steven P. LehrerRita K. SchmutzlerBeth S. Schachter OriginalPaper Pages: 175 - 180
Human breast tumors containing non-DNA-binding immunoreactive (67 kDa) estrogen receptor Pamella A. MontgomeryGary K. ScottChristopher C. Benz OriginalPaper Pages: 181 - 189
The ER-positive / PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain Suzanne A. W. FuquaD. Craig AllredWilliam L. McGuire OriginalPaper Pages: 191 - 202
